Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T26368 | ||||
Target Name | GABA(A) receptor alpha-5 (GABRA5) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | (2E,4S)-4-ammoniopent-2-enoate | Drug Info | IC50 = 2600 nM | [7] | |
(4R)-4-ammoniopentanoate | Drug Info | IC50 = 2500 nM | [7] | ||
(4S)-4-ammoniopentanoate | Drug Info | IC50 = 2900 nM | [7] | ||
3-(3-Methyl-butoxy)-9H-beta-carboline | Drug Info | Ki = 3000 nM | [6] | ||
3-(benzyloxy)-9H-pyrido[3,4-b]indole | Drug Info | Ki = 10000 nM | [6] | ||
3-(hexa-1,3-dienyloxy)-9H-pyrido[3,4-b]indole | Drug Info | Ki = 10000 nM | [6] | ||
3-Butoxy-9H-beta-carboline | Drug Info | Ki = 1000 nM | [6] | ||
3-Ethoxy-9H-beta-carboline | Drug Info | Ki = 826 nM | [6] | ||
3-Isobutoxy-9H-beta-carboline | Drug Info | Ki = 1000 nM | [6] | ||
3-Propoxy-9H-beta-carboline | Drug Info | Ki = 591 nM | [6] | ||
5-[(1R)-1-ammonioethyl]isoxazol-3-olate | Drug Info | IC50 = 9500 nM | [7] | ||
5-[(1S)-1-ammonioethyl]isoxazol-3-olate | Drug Info | IC50 = 5800 nM | [7] | ||
9H-beta-Carboline-3-carboxylic acid ethyl ester | Drug Info | Ki = 26.8 nM | [6] | ||
AMENTOFLAVONE | Drug Info | Ki = 6 nM | [1] | ||
Beta-Carboline-3-carboxylic acid t-butyl ester | Drug Info | Ki = 110.8 nM | [6] | ||
CI-218872 | Drug Info | Ki = 561 nM | [6] | ||
Ethyl 6-iodo-9H-pyrido[3,4-b]indole-3-carboxylate | Drug Info | Ki = 286 nM | [6] | ||
GSK683699 | Drug Info | Ki = 200 nM | [8] | ||
L-655708 | Drug Info | Ki = 0.4 nM | [2] | ||
MRK016 | Drug Info | Ki = 0.2 nM | [3] | ||
Ro-15-3505 | Drug Info | Ki = 54.6 nM | [5] | ||
Ro-4938581 | Drug Info | Ki = 2 nM | [4] | ||
Ro-4938581 | Drug Info | Ki = 4.6 nM | [4] | ||
Sec-butyl 9H-pyrido[3,4-b]indole-3-carboxylate | Drug Info | Ki = 216 nM | [6] | ||
[3H]Ro154513 | Drug Info | Ki = 0.26 nM | [9] | ||
References | |||||
REF 1 | Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptors. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2281-4. | ||||
REF 2 | 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor li... J Med Chem. 2004 Mar 25;47(7):1807-22. | ||||
REF 3 | Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2/alpha3 binding site agonists for the treatment of anxiety... J Med Chem. 2006 Jan 12;49(1):35-8. | ||||
REF 4 | The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment... Bioorg Med Chem Lett. 2009 Oct 15;19(20):5940-4. | ||||
REF 5 | The GABA(A) receptor as a target for photochromic molecules. Bioorg Med Chem. 2010 Nov 15;18(22):7731-8. | ||||
REF 6 | Design, synthesis, and subtype selectivity of 3,6-disubstituted -carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents f... Bioorg Med Chem. 2010 Nov 1;18(21):7548-64. | ||||
REF 7 | gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J Med Chem. 1981 Dec;24(12):1377-83. | ||||
REF 8 | New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide. J Med Chem. 1980 Jun;23(6):702-4. | ||||
REF 9 | Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABA... J Med Chem. 1996 Apr 26;39(9):1928-34. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.